View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
March 29, 2022

Medical Devices industry cross border M&A deals total $472.5m globally in February 2022

By Nikitha Ladda

Total medical devices industry cross border M&A deals worth $472.5m were announced globally in February 2022, led by Dreamtech’s $227.57m acquisition of 9.1% stake in Cardiac Insight, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 20.3% over the previous month of $592.62m and a drop of 71.5% when compared with the last 12-month average, which stood at $1.66bn.

Comparing cross border M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $261.57m. At the country level, the US topped the list in terms of deal value at $261.57m.

In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.

The top country in terms of cross border M&A deals activity in February 2022 was the US with seven deals, followed by the Denmark with three and Germany with three.

In 2022, as of February, medical devices cross border M&A deals worth $1.07bn were announced globally, marking an increase of 42.8% year on year.

medical devices industry cross border M&A deals in February 2022: Top deals

The top three cross border M&A deals accounted for 99.7% of the overall value during February 2022.

The combined value of the top three medical devices cross border M&A deals stood at $471.52m, against the overall value of $472.5m recorded for the month.

The top three medical devices industry cross border M&A deals of February 2022 tracked by GlobalData were:

1) Dreamtech $227.57m acquisition deal for 9.1% stake in Cardiac Insight

2) The $210m private equity deal with Micro Life Sciences by South Elm Investments B V

3) Fagron $34m acquisition deal with Letco Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network